Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

36.50p
   
  • Change Today:
      1.25p
  • 52 Week High: 48.10
  • 52 Week Low: 23.25
  • Currency: UK Pounds
  • Shares Issued: 361.48m
  • Volume: 1,296,494
  • Market Cap: £131.94m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Christopher Paul Hancock 4,802,352 £1,752,858
Richard John Rees 2,805,902 £1,024,154
Craig Jonathan Gulliford 1,630,466 £595,120
John Bradshaw 1,371,082 £500,445
David Gerard Woods 440,255 £160,693
Charles Spicer 308,530 £112,614
Ivonne Cantu 125,000 £45,625

Major Shareholders

Notifier** Holding Value*
Canaccord Genuity Group Inc 39,303,064 £14,345,618
Development Bank of Wales plc 14,376,727 £5,247,505
Finance Wales 12,776,727 £4,663,505
Baillie Gifford & Co 12,537,441 £4,576,166
Creo Medical Group EBT 10,000,000 £3,650,000
M&G Investments 9,428,500 £3,441,402
The Capital Group Companies, Inc. 8,816,807 £3,218,135
AXA Framlington Investment Managers 7,992,961 £2,917,431
Hargreave Hale Limited 6,753,632 £2,465,076
Tellworth Investments 5,772,778 £2,107,064
Hoya Corporation 4,799,880 £1,751,956
Jonathan Craton 3,400,294 £1,241,107
Cotterford Co Limited 3,335,398 £1,217,420
Mark Farmer 3,121,607 £1,139,387
RBC Trustees (CI) Ltd 2,974,727 £1,085,775
Angel Co Fund 2,967,120 £1,082,999

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 36.50p
Change Today 1.25p
% Change 3.55 %
52 Week High 48.10
52 Week Low 23.25
Volume 1,296,494
Shares Issued 361.48m
Market Cap £131.94m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
16.17% below the market average16.17% below the market average16.17% below the market average16.17% below the market average16.17% below the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average
Price Trend
20.26% above the market average20.26% above the market average20.26% above the market average20.26% above the market average20.26% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Income Not Available
Growth
15.59% above the market average15.59% above the market average15.59% above the market average15.59% above the market average15.59% above the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 31-May-2024

Time Volume / Share Price
16:14 100,000 @ 36.50p
17:08 20,500 @ 36.50p
15:47 27,108 @ 36.87p
15:22 500 @ 36.30p
15:22 481 @ 36.88p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page